Patients with HCC with high EZH2-C levels and low EZH2-A levels have longer overall survival, thus EZH2-C and EZH2-A could be used as prognostic markers for postoperative survival in HCC. This evidence concerns the gene EZH2 and hepatocellular carcinoma.